MWP
TMO icon

Meridian Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Meridian Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$205K Sell
418
-3
-0.7% -$1.63K 0.03% 116
2025
Q4 		$244K Sell
421
-3
-0.7% -$1.7K 0.03% 97
2025
Q3 		$206K Buy
+424
New +$197K 0.03% 112
2025
Q2 		– Sell
-430
Closed -$214K – 115
2025
Q1 		$214K Sell
430
-12
-3% -$6.5K 0.03% 97
2024
Q4 		$230K Sell
442
-71
-14% -$39K 0.03% 99
2024
Q3 		$317K Sell
513
-6
-1% -$3.55K 0.05% 81
2024
Q2 		$287K Buy
519
+32
+7% +$18.3K 0.05% 85
2024
Q1 		$283K Buy
487
+37
+8% +$20.8K 0.05% 85
2023
Q4 		$239K Sell
450
-35
-7% -$16.9K 0.05% 91
2023
Q3 		$246K Sell
485
-14
-3% -$7.46K 0.05% 81
2023
Q2 		$260K Sell
499
-12
-2% -$6.48K 0.05% 78
2023
Q1 		$295K Buy
511
+64
+14% +$36.1K 0.06% 68
2022
Q4 		$246K Buy
+447
New +$237K 0.06% 74
2022
Q1 		– Sell
-317
Closed -$211K – 90
2021
Q4 		$211K Buy
+317
New +$198K 0.04% 77
2021
Q2 		– Sell
-297
Closed -$136K – 1150
2021
Q1 		$136K Buy
297
+11
+4% +$5.25K 0.04% 88
2020
Q4 		$133K Buy
286
+10
+4% +$4.69K 0.05% 81
2020
Q3 		$122K Buy
276
+1
+0.4% +$413 0.06% 79
2020
Q2 		$99K Buy
275
+1
+0.4% +$335 0.05% 93
2020
Q1 		$78K Sell
274
-9
-3% -$2.84K 0.05% 101
2019
Q4 		$92K Buy
+283
New +$85.8K 0.06% 99

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meridian Wealth Partners's TMO Position: Q1 2026 in Review

Meridian Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 0.71% in Q1 2026, selling an estimated $1.63K and leaving 418 shares worth $205K. The position accounts for 0.03% of the portfolio, ranked #116.

Meridian Wealth Partners first reported a position in TMO in Q4 2019 and has held it in 20 quarters since. The position peaked at $317K in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Meridian Wealth Partners held 418 shares of Thermo Fisher Scientific worth $205K as of Q1 2026.
  • Meridian Wealth Partners sold 3 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.63K.
  • Thermo Fisher Scientific made up 0.03% of Meridian Wealth Partners's portfolio in Q1 2026, its #116 holding.
  • Meridian Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 20 quarters since.
  • Meridian Wealth Partners's Thermo Fisher Scientific position peaked at $317K in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Meridian Wealth Partners's 13F filing for Q1 2026, filed 14 May 2026.